Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 10,889 | 9,225 | 9,124 | 11,413 | 10,299 |
| Cost of Goods | 1,521 | 1,250 | 2,650 | 2,224 | 2,032 |
| Gross Profit | 9,368 | 7,974 | 6,473 | 9,189 | 8,267 |
| Operating Expenses | 9,866 | 9,756 | 9,402 | 9,702 | 10,146 |
| Operating Income | 23 | -1,532 | -2,278 | -289 | -1,847 |
| Interest Expense | 193 | 186 | 180 | 149 | 138 |
| Other Income | 1,039 | 1,897 | 46 | 22 | 626 |
| Pre-tax Income | 869 | 179 | -2,412 | -416 | -1,358 |
| Income Tax | 7 | 7 | 62 | -7 | 7 |
| Net Income Continuous | 862 | 172 | -2,474 | -409 | -1,365 |
| Minority Interests | -10 | -20 | -19 | -15 | -29 |
| Net Income | $872 | $192 | $-2,441 | $-409 | $-1,336 |
| EPS Basic Total Ops | 0.06 | 0.01 | -0.17 | -0.03 | -0.09 |
| EPS Basic Continuous Ops | 0.06 | 0.01 | -0.17 | -0.03 | -0.09 |
| EPS Diluted Total Ops | 0.06 | 0.01 | -0.17 | -0.03 | -0.09 |
| EPS Diluted Continuous Ops | 0.06 | 0.01 | -0.17 | -0.03 | -0.09 |
| EBITDA(a) | $1,224 | $-276 | $-1,766 | $1,256 | $-228 |